Skip to main content

Blue Jays led MLB with the most minor-leaguers found using banned substances

Toronto Blue Jays general manager Ross Atkins has ordered an internal investigation to try to determine the reasons behind the sudden spike in performance-enhancing drug suspensions.

Nathan Denette/THE CANADIAN PRESS

The Toronto Blue Jays led Major League Baseball in one capacity this year, but it is not one the organization is proud of.

On Tuesday, MLB suspended three players in the Blue Jays minor-league system for using performance-enhancing drugs. That makes seven Toronto minor-leaguers who have been caught cheating this season, the highest of any team.

The Seattle Mariners, with five players nabbed, are second on that list.

Story continues below advertisement

There were 79 players from the 30 clubs who were found to be in contravention of the league's Minor League Drug Prevention and Treatment Program.

In 2016, the Blue Jays had six minor-leaguers test positive for banned substances.

No other team in the majors can match the Blue Jays' 13 failed drug tests over the past two years. The New York Yankees are No. 2 with 11.

The high number of drug infractions in Toronto's minor-league system is distressing to club general manager Ross Atkins, who has ordered an internal investigation to try to determine the reasons behind the sudden spike.

"This situation is very disappointing and disturbing to the organization; disappointing that the players made these choices, but more so disturbing that some failure of our environment allowed this to happen," Atkins said in a statement released by the club Thursday. "It is our responsibility to create an environment and culture where our players know that PED use is not condoned, and to give them resources and education to ensure that they do not make these decisions.

"As we seek to determine both how and why this happened, an internal investigation into the situation remains ongoing, and we will double down on ensuring that all our staff is properly equipped to help our players make the right choices."

All seven of the players caught this year started the season in the rookie-level Dominican Summer League. They are not household names.

Story continues below advertisement

Earlier this week, right-handed pitcher Juan Jimenez and left-handed pitcher Naswell Paulino each received 72-game suspensions after testing positive for Boldenone, an anabolic-androgenic steroid developed for veterinary use.

Right-handed pitcher Jol Concepcion, who was promoted to the rookie-level Gulf Coast League Blue Jays, received a 60-game penalty, also for using Boldenone. Last week, MLB suspended shortstop Hugo Cardona (72 games), infielder Yhon Perez (72 games) and catcher Leonico Ventura (72 games). As in the other cases, Boldenone was the drug of choice.

On Sept. 1, Toronto minor-league pitcher Luis Pena was suspended for 72 games after testing positive for Stanozolol, an anabolic steroid.

When contacted by telephone on Thursday, Atkins did not want to talk about the matter, referring a reporter to his statement.

In the statement Atkins said the Blue Jays support MLB's continuing program to combat illegal drug use at the minor-league level "and will continue to collaborate with MLB on all matters relating to PED abuse."

Report an error Editorial code of conduct
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

If your comment doesn't appear immediately it has been sent to a member of our moderation team for review

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.